Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

Traumatic Brain Injury, PTSD Associated With Alzheimer's: Research

The medical profession has never before investigated the effects of traumatic brain injury (TBI), post-traumatic stress disorder (PTSD) and genetic risk factors in a sizable cohort. Read on for details:

Dynamite News

Researchers find signs of Alzheimer's disease in dolphins

Researchers in Scotland have found dolphins with classic markers of Alzheimer's disease in their brains, potentially pointing to the reason the animals became stranded.

ABC News

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

On Nov. 30, Eisai and Biogen announced the results of their latest phase 3 clinical trial in Alzheimer’s disease. The verdict: an 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The study…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Dolphins may suffer from Alzheimer’s disease, say researchers in Scotland

Bottlenose dolphin, a long-finned pilot whale and a third species found to have markers of the degenerative disease

The Guardian - UK

Stranded dolphins’ brains show common signs of Alzheimer’s disease – study

The findings might help explain why some species get stranded, researchers say.

The Independent UK

Dolphins may suffer brain damage similar to Alzheimer’s disease

A new study shows four animals from different dolphin species have some of the brain changes associated with human Alzheimer’s disease

The Independent UK

Why does the Alzheimer's brain become insulin-resistant?

As the population ages, the number of people with neurodegenerative diseases, such as Alzheimer’s disease, increases. Approximately 75,000 Canadians are diagnosed with Alzheimer’s disease each year and experience a decline in their cognitive abilities. The ordeal usually lasts for several years while their family members watch helplessly.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

The first study to measure vitamin D in the brain could help reveal how to maintain cognitive health

A new study found a link between higher concentrations of Vitamin D and improved cognition in aging people.

Inverse

Commentary: By sharing their genetic risks, Hemsworth, Jolie are raising awareness of testing

When actor Chris Hemsworth, aka Thor, God of Thunder, agreed to host a National Geographic series about extending the human life span, he didn’t expect to discover a genetic risk of his own. But that’s what happened as Hemsworth revealed on an episode of “Limitless” that he carries a common…

Chicago Tribune

Harnessing the brain's immune cells to stave off Alzheimer's and other neurodegenerative diseases

Many neurodegenerative diseases, or conditions that result from the loss of function or death of brain cells, remain largely untreatable. Most available treatments target just one of the multiple processes that can lead to neurodegeneration, which may not be effective in completely addressing disease symptoms or progress, if at all.

The Conversation

Blood test could detect Alzheimer's disease years before symptoms

The new test could detect a toxic protein which has been linked to Alzheimer's disease years before any symptoms appear in the patient

Wales Online

Blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms – study

Currently patients tend to receive a diagnosis of Alzheimer’s only after they show well-known signs of the disease.

The Independent UK

Trial offers new hope for Alzheimer's Disease treatment

Hunter residents at high risk of developing Alzheimer's Disease will be given access to a clinical trial involving a breakthrough drug that appears to slow the development of the disease.

Newcastle Herald

New drug is 'beginning of the end' of Alzheimer's - who will it help and when will it be available?

Lecanemab has been shown in trials to slow the progress of early-stage Alzheimer's by 27%

Wales Online

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Exciting new drug is ‘beginning of the end’ for Alzheimer’s – so what is it and when could it be available?

As trial results bring hope of an effective treatment, Lisa Salmon asks The Alzheimer’s Society what it means for people right now.

Manchester Evening News

Drug proven to slow decline in Alzheimer patients

Lecanemab, a newly developed drug, has showed promising results in clinical trials among Alzheimer patients

The New Daily

‘Momentous breakthrough’: New Alzheimer’s drug lives up to bold claims, with caveats

Data supports claims that a new drug reduced cognitive and functional decline in Alzheimer's patients by 27 per cent in a clinical trial.

Daily Record

New Alzheimer's drug hailed as 'game-changing' as it's proven to slow disease

The drug slowed the disease progression by 27 percent compared to patients taking the placebo.

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease

Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease

Wales Online

Simple urine test could be used to diagnose early-stage Alzheimer’s disease

The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment

The Independent UK

Molecule in urine ‘could be the first to reveal early-stage Alzheimer’s disease’

The findings suggest a simple urine test could be used to identify people who are in the early stages of the disease.

Wales Online

New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment

Clinical results suggest that the disease progression can by slowed by 27%

The Independent UK

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Lecanemab was found to slow decline in patients’ memory and thinking.

The Conversation

Another Alzheimer’s drug fails in late-stage trials – what now?

Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab.

Evening Standard

How likely is Chris Hemsworth to get Alzheimer’s disease and what are its signs?

The actor told Vanity Fair the discovery he is at high risk is his ‘biggest fear’ but said: ‘It’s not like I’ve been handed my resignation’

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Glasgow

University of Washington

New England Journal of Medicine

31 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.